News | Artificial Intelligence | June 09, 2023

AI for Preprocedural TAVR Modeling Gains FDA Clearance

Dasi Simulations announced it received FDA clearance for its artificial intelligence model for preprocedure transcatheter aortic valve replacement modeling. 

June 9, 2023 — Dasi Simulations announced it received FDA clearance for its artificial intelligence model for preprocedure transcatheter aortic valve replacement modeling. 

The AI (Precision TAVI) is the company’s first product to be cleared by the FDA, according to a company press release. 

“Dasi Simulations empowers every heart team with critical insights guaranteeing the identification of the best possible care for individual patients, customized to their unique circumstances and anatomy,” Lakshmi (Prasad) Dasi, PhD, FACC, FAIMBE, cofounder and chief technology officer of Dasi Simulations, said in the release. “One surgery at a time, our technology helps avoid complications, repeated interventions, helps lifelong planning for optimal structural heart care, and has the potential to save billions in unnecessary costs from preventable complications.” 

The technology was initially licensed through The Ohio State University and subsequently through an inter-institutional agreement including Georgia Institute of Technology, Emory University and Piedmont Hospital Atlanta, according to the release. 

“Our game-changing approach has paved the way for the first approved personalized computer simulations in the heart valve space,” Teri Sirset, cofounder and CEO of Dasi Simulations, said in the release. “While the journey to approval typically spans years, we shattered expectations by achieving this milestone in less than 14 months. This achievement showcases our resilience and dedication to transforming patient care, one groundbreaking innovation at a time.” 

For more information: www.dasisim.com


Related Content

News | Structural Heart

February 20, 2024 — As New Jersey’s leading provider of high-quality cardiac procedures and diagnostic testing and an ...

Home February 20, 2024
Home
News | Structural Heart

February 15, 2024 — Abbott announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee ...

Home February 15, 2024
Home
News | Structural Heart

February 9, 2024 — Physicians in the Smidt Heart Institute at Cedars-Sinai have achieved two significant firsts ...

Home February 09, 2024
Home
News | Structural Heart

January 4, 2024 — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural ...

Home January 04, 2024
Home
News | Structural Heart

December 12, 2023 — Think of them as the Energizer Bunnies of the heart, tiny natural batteries that keep this vital ...

Home December 12, 2023
Home
News | Structural Heart

October 31, 2023 — Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized ...

Home October 31, 2023
Home
News | Structural Heart

October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...

Home October 26, 2023
Home
News | Structural Heart

October 19, 2023 — The Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for ...

Home October 19, 2023
Home
News | Structural Heart

October 19, 2023 — Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system ...

Home October 19, 2023
Home
News | Structural Heart

October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which ...

Home October 12, 2023
Home
Subscribe Now